03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Granocyte 34* : | |
Type | Medicine Non Marketed |
Originator | Biotech (Granocyte 34) |
Agent | Mersaco |
Distributor | Mersaco |
Laboratory | Sanofi |
Responsible Party | Chugai Sanofi Aventis |
Origin | France |
Manufacturer | Sanofi Winthrop Industrie |
Origin | France |
ATC | L03AA10 |
Granocyte 34* :
Granocyte 34* :
Granocyte 34* :
Granocyte 34* :
Granocyte 34* :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Granocyte 34* :
Granocyte 34* :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abdominal pain | Common |
Acute febrile neutrophilic dermatosis (Sweet's syndrome) | Very rare |
Allergic reaction | Very rare |
ALT increased | Very Common |
Anaphylactic shock | Very rare |
AST increased | Very Common |
Back pain | Very Common |
Bone pain | Very Common |
Capillary leak syndrome | Uncommon |
Cephalea | Very Common |
Cutaneous vasculitis | Very rare |
Erythema nodosum | Very rare |
Fatigue | Very Common |
Injection site reaction | Common |
Interstitial pneumonia | Rare |
LDH elevated | Very Common |
Leukocytosis | Very Common |
Lung infiltration (pulmonary infiltration) | Rare |
Lyell Syndrome (Toxic epidermal necrolysis) | Very rare |
Pain | Common |
Phosphatase alkaline increased | Very Common |
Pulmonary fibrosis | Rare |
Pulmonary oedema | Rare |
Pyoderma gangrenosum | Very rare |
Splenic rupture | Very rare |
Splenomegaly (Spleen enlarged) | Common |
Thrombocytopenia (Thrombopenia) | Very Common |
Granocyte 34* :
NB : Products With Same Indication |
Different Units By MoH Code
Granocyte 34* MoH 6801 :
Form | Powder and solvent for solution for injection/infusion |
Packaging | Pre-filled Syringe + Vial |
Package Size | 5+5x1ml |
Strength | 34MIU (263µg) |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 97220/12 |
Submission date | 01/01/2012 |
Registration Year | 2012 |
Archived Date | 01/04/2020 |
Price Comparison
● Country: | Kuweit | |
● Package Size: | 5+5x1ml | |
● Public Price: | 261 KWD | ( 76,624,641.00 LBP ) |
● Pack size unit used: | 5 | |
● Cost/Unit: | 52,2 KWD | ( 15,266,212.00 LBP ) |
● Pharmacy Price: | 220.5 KWD | ( 64734610.5 LBP ) |
● Pricing Date: | 07/02/2021 | |
● Type: | Medicine Authorised |
● Country: | Italy | |
● Package Size: | 1 | |
● Public Price: | 131.02 EUR | ( 12,692,693.52 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 131,02 EUR | ( 12,690,756.00 LBP ) |
● Pricing Date: | 17/12/2019 | |
● Type: | Medicine Authorised |
● Country: | Switzerland | |
● Package Size: | 5 | |
● Public Price: | 535.7 CHF | ( 55,402,094.00 LBP ) |
● Pack size unit used: | 5 | |
● Cost/Unit: | 107,14 CHF | ( 11,065,940.00 LBP ) |
● Exfactory Price: | 452.35 CHF | |
● Pricing Date: | 04/04/2021 | |
● Type: | Medicine Authorised |
● Country: | Denmark | |
● Package Size: | 5 | |
● Public Price: | 3629.8 DKK | ( 47,100,284.80 LBP ) |
● Pack size unit used: | 5 | |
● Cost/Unit: | 725,96 DKK | ( 9,407,600.00 LBP ) |
● Pharmacy Price: | 2693.65 DKK | ( 34952802.4 LBP ) |
● Reference: | Danish Medicine Agency | |
● Pricing Date: | 19/05/2021 | |
● Type: | Medicine Authorised |
● Country: | France | |
● Package Size: | 5 | |
● Public Price: | 466.95 EUR | ( 45,236,248.20 LBP ) |
● Pack size unit used: | 5 | |
● Cost/Unit: | 93,39 EUR | ( 9,009,468.00 LBP ) |
● Reference: | ansm | |
● Pricing Date: | 15/05/2021 | |
● Type: | Medicine Authorised |
● Country: | Cyprus | |
● Package Size: | 5+5x1ml | |
● Public Price: | 424.82 EUR | ( 41,154,862.32 LBP ) |
● Pack size unit used: | 5 | |
● Cost/Unit: | 84,964 EUR | ( 8,137,584.00 LBP ) |
● Reference: | Cyprus Minister of Health | |
● Pricing Date: | 24/03/2021 | |
● Type: | Medicine Authorised |
● Country: | Belgium | |
● Package Size: | 5 | |
● Public Price: | 381.13 EUR | ( 36,922,349.88 LBP ) |
● Pack size unit used: | 5 | |
● Cost/Unit: | 76,226 EUR | ( 7,362,576.00 LBP ) |
● Reference: | cbip | |
● Pricing Date: | 27/11/2020 | |
● Type: | Medicine Authorised |
● Country: | UK | |
● Package Size: | 5 | |
● Public Price: | 312.69 GBP | ( 35,536,905.81 LBP ) |
● Pack size unit used: | 5 | |
● Cost/Unit: | 62,538 GBP | ( 7,046,238.00 LBP ) |
● Reference: | DMD | |
● Pricing Date: | 08/03/2021 | |
● Type: | Medicine Withdrawn |
● Country: | Spain | |
● Package Size: | 5+5x1ml | |
● Public Price: | 349.2 EUR | ( 33,829,099.20 LBP ) |
● Pack size unit used: | 5 | |
● Cost/Unit: | 69,84 EUR | ( 6,684,444.00 LBP ) |
● Reference: | Agencia Española de Medicamentos y Productos Sanitarios | |
● Pricing Date: | 06/05/2021 | |
● Type: | Medicine Non Marketed |
● Country: | Sweden | |
● Package Size: | 5 | |
● Public Price: | 3738.86 SEK | ( 31,436,334.88 LBP ) |
● Pack size unit used: | 5 | |
● Cost/Unit: | 747,772 SEK | ( 6,280,776.00 LBP ) |
● Pharmacy Price: | 3620.21 SEK | ( 30438725.68 LBP ) |
● Pricing Date: | 23/04/2020 | |
● Type: | Medicine Authorised |
● Country: | Ireland | |
● Package Size: | 5 | |
● Public Price: | 319.45 EUR | ( 30,947,038.20 LBP ) |
● Pack size unit used: | 5 | |
● Cost/Unit: | 63,89 EUR | ( 6,103,188.00 LBP ) |
● Pricing Date: | 08/10/2020 | |
● Type: | Medicine Authorised |
● Country: | Greece | |
● Package Size: | 5+5x1ml | |
● Public Price: | 263.85 EUR | ( 25,560,732.60 LBP ) |
● Pack size unit used: | 5 | |
● Cost/Unit: | 52,77 EUR | ( 5,037,552.00 LBP ) |
● Exfactory Price: | 218.95 EUR | |
● Pharmacy Price: | 222.24 EUR | ( 21529722.24 LBP ) |
● Reference: | National Organization for Medicines | |
● Pricing Date: | 25/02/2021 | |
● Type: | Medicine Authorised |
● Country: | Turkey | |
● Package Size: | 1 | |
● Public Price: | 362.94 TRY | ( 972,679.20 LBP ) |
● Pack size unit used: | 1 | |
● Cost/Unit: | 362,94 TRY | ( 970,160.00 LBP ) |
● Pricing Date: | 31/12/2019 | |
● Type: | Medicine Authorised |
● Country: | Egypt |
● Package Size: | 5+5x1ml |
● Pricing Date: | 02/12/2019 |
● Type: | Medicine Authorised |
Note
You have to register to view this info
Drop File